Search results
Buy Biocon; target of Rs 400: Sharekhan
CNBC Awaaz· 20 minutes agoSharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 400 in its research report dated June 28, 2024.
GAIL shares rise 0.22% as Nifty gains
The Economic Times· 21 minutes agoAs many as 621,296 shares changed hands on the counter with a total value of Rs 13.71 crore. The stock quoted a 52-week high price of Rs 233.0 and a 52-...
Budget 2024 should hike basic income tax exemption limit to Rs 5 lakh in both old and new tax...
The Economic Times· 23 minutes agoThe Union Budget 2024 is set to be unveiled by Finance Minister Nirmala Sitharaman in July 2024. Revamping tax slab benefitsUnion Budget 2023 made significant changes to & ...
The positive impacts and challenges of GST across sectors
Financial Express· 32 minutes agoOn this GST Day, as the Goods and Services Tax (GST) completes seven years in India, we look forward...
Japan revises economic growth in 1Q downward, as latest data show sluggish demand and rising prices
CNBC Awaaz· 32 minutes agoJapan revised its earlier estimates to show that its economy contracted at a 2.9% annual pace in the...
Shares of Bandhan Bank rise as Nifty gains - The Economic Times
The Economic Times· 34 minutes agoIt hit a high of Rs 205.95 and low of Rs 203.75 during the session. The stock quoted a 52-week high...
Japan imposes new fees on Mount Fuji climbers to limit tourists
CNBC Awaaz· 34 minutes agoClimbers must pay 2,000 yen ($12) and their numbers will be limited to 4,000 a day after complaints...
BTS' Jungkook and Lovely Runner’s Byeon Woo Seok's looks in same sporty jacket go viral: Who wore it...
Pinkvilla· 36 minutes agoRecently, Byeon Woo Seok, the actor who recently starred in K-drama Lovely Runner, was spotted...
Kanye West escapes financial woes by flying privately to Moscow, fans rally outside his hotel
CNBC Awaaz· 36 minutes agoKanye West's recent trip to Moscow has stirred curiosity, especially in the US. He arrived quietly, sparking controversy. Despite being there, he has stayed out of
MC Inside Edge: Remus in AK-47’s crosshairs, old timer scores big with Idea, HNIs cling to Indus...
CNBC Awaaz· 36 minutes agoTurnaround story Remus Pharma saw a spike in trading volumes on Friday. Chatter is that the AK-47 of small and micro caps has begun nibbling at the stock ...
